Q32 Bio (QTTB) Enterprise Value (2017 - 2025)
Historic Enterprise Value for Q32 Bio (QTTB) over the last 9 years, with Q3 2025 value amounting to -$68.9 million.
- Q32 Bio's Enterprise Value rose 2260.27% to -$68.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$68.9 million, marking a year-over-year increase of 2260.27%. This contributed to the annual value of -$78.0 million for FY2024, which is 20434.87% down from last year.
- Q32 Bio's Enterprise Value amounted to -$68.9 million in Q3 2025, which was up 2260.27% from -$54.8 million recorded in Q2 2025.
- In the past 5 years, Q32 Bio's Enterprise Value ranged from a high of -$25.6 million in Q4 2023 and a low of -$256.1 million during Q1 2022
- Its 5-year average for Enterprise Value is -$134.6 million, with a median of -$135.3 million in 2024.
- Its Enterprise Value has fluctuated over the past 5 years, first skyrocketed by 8536.39% in 2023, then plummeted by 20434.87% in 2024.
- Over the past 5 years, Q32 Bio's Enterprise Value (Quarter) stood at -$157.8 million in 2021, then fell by 10.9% to -$175.0 million in 2022, then surged by 85.36% to -$25.6 million in 2023, then tumbled by 204.35% to -$78.0 million in 2024, then rose by 11.57% to -$68.9 million in 2025.
- Its Enterprise Value was -$68.9 million in Q3 2025, compared to -$54.8 million in Q2 2025 and -$65.5 million in Q1 2025.